Overview

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets innovative products and has a broad portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc.

NYSE: PEN 147.81 -2.27 -1.51%
Volume: 570,359
Pricing delayed 20 minutes September 19, 2019 04:01 PM

SEC Filings

Date Filing Type Filing Description Download
Date September 18, 2019 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date September 17, 2019 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date September 16, 2019 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA